Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Interest & Investment Income (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Interest & Investment Income for 2 consecutive years, with $167311.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 446.5% to $167311.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $409094.0, a N/A change, with the full-year FY2025 number at $166498.0, down 24.35% from a year prior.
  • Interest & Investment Income was $167311.0 for Q4 2025 at Neuphoria Therapeutics, up from $141996.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $167311.0 in Q4 2025 to a low of $12741.0 in Q1 2025.